id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-P-0329-0010,FDA,FDA-2005-P-0329,Denial Letter from FDA CDER to Camargo Pharmaceutical Services,Other,Denial,2021-11-23T05:00:00Z,2021,11,2021-11-23T05:00:00Z,,2025-04-24T12:23:06Z,,0,0,0900006484e76a9a
FDA-2005-P-0329-0005,FDA,FDA-2005-P-0329,Attachment 2 Prescribing information Mobic (Meloxicam) re: Citizen Petition from Camargo Pharmaceutical Services,Supporting & Related Material,Background Material,2015-09-30T04:00:00Z,2015,9,,,2015-09-30T16:07:37Z,,0,0,090000648044869c
FDA-2005-P-0329-0003,FDA,FDA-2005-P-0329,Citizen Petition from Camargo Pharmaceutical Services,Other,Citizen Petition,2015-09-30T04:00:00Z,2015,9,2015-09-30T04:00:00Z,,2025-04-24T12:21:27Z,,0,0,09000064804486ad
FDA-2005-P-0329-0006,FDA,FDA-2005-P-0329,Attachment 3 Prescribing Information Meloxicam Orally Disintegrating Tablet re: Citizen Petition from Camargo Pharmaceutical Services,Supporting & Related Material,Background Material,2015-09-30T04:00:00Z,2015,9,,,2015-09-30T16:11:17Z,,0,0,09000064804486b2
FDA-2005-P-0329-0007,FDA,FDA-2005-P-0329,"Attachment 4 Letter from FDA CDER to Boehringer Ingelheim Pharmaceuticals, Inc. re: Citizen Petition from Camargo Pharmaceutical Services",Supporting & Related Material,Background Material,2015-09-30T04:00:00Z,2015,9,,,2015-09-30T16:17:45Z,,0,0,09000064804486b3
FDA-2005-P-0329-0009,FDA,FDA-2005-P-0329,Background Material from Camargo Pharmaceutical Services,Supporting & Related Material,Background Material,2015-09-30T04:00:00Z,2015,9,,,2015-09-30T16:21:59Z,,0,0,0900006481ca55ef
FDA-2005-P-0329-0004,FDA,FDA-2005-P-0329,Attachment 1 Orange Book Listings for Meloxicam re: Citizen Petition from Camargo Pharmaceutical Services,Supporting & Related Material,Background Material,2015-09-30T04:00:00Z,2015,9,,,2025-04-24T12:22:16Z,,0,0,09000064804486b0
FDA-2005-P-0329-0008,FDA,FDA-2005-P-0329,Letter from Camargo Pharmaceutical Services to FDA CDER,Other,Letter(s),2015-09-30T04:00:00Z,2015,9,2015-09-30T04:00:00Z,,2025-04-24T12:22:45Z,,0,0,0900006481ca48eb
FDA-2005-P-0329-0002,FDA,FDA-2005-P-0329,Acknowledgement Letter from FDA DDM to Camargo Pharmaceutical Services,Other,Acknowledgement Letter/Receipt,2005-11-25T05:00:00Z,2005,11,,,2025-04-24T12:20:39Z,,0,0,09000064804486b4
FDA-2005-P-0329-0001,FDA,FDA-2005-P-0329,Acknowledgement Letter from FDA DDM to Camargo Pharmaceutical Services,Other,Acknowledgement Letter/Receipt,2005-11-25T05:00:00Z,2005,11,,,2025-04-24T12:19:27Z,,0,0,0900006480448649